← FDA DRUG APPROVALS

FDA ANDA · ANDA219408

DAPAGLIFLOZIN

Sponsor: SCIEGEN PHARMACEUTICALS INC

APPLICATION
ANDA219408
TYPE
ANDA
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)

Products

DAPAGLIFLOZINNone (Tentative Approval)
DAPAGLIFLOZIN 10MG · TABLET
DAPAGLIFLOZINNone (Tentative Approval)
DAPAGLIFLOZIN 5MG · TABLET

Approval history

2026-04-30UNKNOWN · Original · standardTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →